Back to calendar
Ligand Pharmaceuticals Incorporated (LGND) Earnings
LGND reports earnings on Thursday, November 5, 2026
earnings report
November 5, 2026 · Before Market Open
Q3 2026
Est. EPS: $2.30
Actual EPS: $2.37
EPS surprise: 17.92%
Company overview
Market Cap$5.7B
PriceUSD 284.10
P/E30.37
EPS (TTM)9.35
52-week high326.63
52-week low160.80
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees47